Program Details

Download Programme Book
Friday, 30 Oct 2020
Room 2

Women in EP - Empowerment through Engagement
09:30 - 10:30Chairmans: Karen  PHILIPS (Australia)
Kyoko SOEJIMA (Japan)
How real time visualization of activation sequence helps to locate gaps in complex arrhythmias?Monica LO (USA)
Reducing fluoroscopy in the EP lab – safety and efficacyLi-Hui ZHENG (China)

Scientific and Practical Perspectives of NOAC Treatment in Stroke Prevention of Asian Patients with Atrial Fibrillation
12:40 - 14:10Chairman: Chu-Pak LAU (Hong Kong)
Atrial fibrillation in Asian population: Applying results from ENGAGE AF-TIMI 48Bryan YAN (Hong Kong)
Scientific view: NOAC real world evidence and ETNA-AF AsiaChun-Chieh WANG (Taiwan)
Practical view: optimized choice of anticoagulation - NOAC in high risk af patients (Cases study)Thoranis CHANTRARAT (Thailand)

Joint EHRA Symposium : AF Screening in Asia-Pacific Regions and Europe
14:30 - 16:00Chairmans: Tze-Fan CHAO (Taiwan)
Hein HEIDBUCHEL (Belgium)
Updates of 2020 ESC guidelines about AF screeningHelmut Pürerfellner (Austria)
The knowns and unknowns in AF screening in the AP region – How did we start the APHRS practice guidelines?Ngai-Yin CHAN (Hong Kong)
The knowns and unknowns in AF screening in EuropeGiuseppe BORIANI (Italy)
The future of AF screeningBen FREEDMAN (Australia)

Role of NOAC in Dual Pathway Inhibition in CAD and PAD: From Trial Results to Guidelines and Beyond
16:20 - 17:50Chairmans: Rungroj KRITTAYAPHONG (Thailand)
Hsuan-Ming TSAO (Taiwan)
Secondary prevention of atherosclerosis: what are we looking for?Rungroj KRITTAYAPHONG (Thailand)
Dual pathway inhibition in secondary prevention in CAD: what more can we do?Mann CHANDAVIMOL (Thailand)
Dual pathway inhibition in chronic PAD: what more can we do?Nattawut WONGPRAPARUT (Thailand)

( Updated as of 23 Oct 2020 )
Remark: The above programs are subject to change without prior notice.